HomeCompareBCCOY vs PLD

BCCOY vs PLD: Dividend Comparison 2026

BCCOY yields 533.33% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BCCOY wins by $101493.72M in total portfolio value
10 years
BCCOY
BCCOY
● Live price
533.33%
Share price
$0.38
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$101500.22M
Annual income
$74,150,491,507.64
Full BCCOY calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — BCCOY vs PLD

📍 BCCOY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBCCOYPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BCCOY + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BCCOY pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BCCOY
Annual income on $10K today (after 15% tax)
$45,333.33/yr
After 10yr DRIP, annual income (after tax)
$63,027,917,781.49/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, BCCOY beats the other by $63,023,449,810.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BCCOY + PLD for your $10,000?

BCCOY: 50%PLD: 50%
100% PLD50/50100% BCCOY
Portfolio after 10yr
$50753.36M
Annual income
$37,077,873,971.91/yr
Blended yield
73.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

BCCOY
No analyst data
Altman Z
-2.5
Piotroski
4/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BCCOY buys
0
PLD buys
0
No recent congressional trades found for BCCOY or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBCCOYPLD
Forward yield533.33%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$101500.22M$6.50M
Annual income after 10y$74,150,491,507.64$5,256,436.18
Total dividends collected$99158.23M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: BCCOY vs PLD ($10,000, DRIP)

YearBCCOY PortfolioBCCOY Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$64,033$53,333.33$11,255$555.24+$52.8KBCCOY
2$387,685$319,169.26$13,062$1,018.59+$374.6KBCCOY
3$2,220,791$1,805,968.17$15,903$1,926.67+$2.20MBCCOY
4$12,044,657$9,668,410.74$20,839$3,823.32+$12.02MBCCOY
5$61,894,777$49,006,993.47$30,464$8,166.08+$61.86MBCCOY
6$301,588,053$235,360,641.70$52,054$19,457.30+$301.54MBCCOY
7$1,394,490,436$1,071,791,219.76$109,886$54,188.93+$1394.38MBCCOY
8$6,123,670,416$4,631,565,648.90$304,030$186,451.18+$6123.37MBCCOY
9$25,560,497,666$19,008,170,321.16$1,166,125$840,813.32+$25559.33MBCCOY
10$101,500,224,010$74,150,491,507.64$6,504,190$5,256,436.18+$101493.72MBCCOY

BCCOY vs PLD: Complete Analysis 2026

BCCOYStock

BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation. The Laboratory Solutions segment offers 3D bioprinters, hybrid microscopes, single-cell dispensing instruments, and liquid handling instruments, as well as services and related consumables, such as bioinks, reagents, microscope lenses, software, printheads, and 3D reconstructed human tissues for applications in regulatory testing. This segment also offers services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology to pharmaceutical and biotechnology companies. The Bioautomation segment offers products in precision dispensing and biosensor technology to the industrial customer; and diagnostics automation and advanced robotics solutions for the medical and diagnostic industries. In addition, it offers core industrial ecosystem, tissue engineering, multi-omics, cell line development, and diagnostics solutions. It primarily serves medical, pharmaceutical, and cosmetic industries. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was founded in 2016 and is based in Gothenburg, Sweden.

Full BCCOY Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this BCCOY vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BCCOY vs SCHDBCCOY vs JEPIBCCOY vs OBCCOY vs KOBCCOY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.